| Literature DB >> 23498296 |
Elizabeth M Venditti1, M Kaye Kramer.
Abstract
The gap between what is known from clinical efficacy research and the systematic community translation of diabetes prevention programs is narrowing. During the past 5 years, numerous randomized and nonrandomized dissemination studies have evaluated the modified delivery of structured Diabetes Prevention Program (DPP) interventions in diverse real-world settings. Programs of sufficient dose and duration, implemented with fidelity, have reported weight losses in the range of 4%-7% with associated improvements in cardiometabolic risk factors at 6 and 12 months from baseline. The current article describes some of the experiences and perspectives of a team of University of Pittsburgh researchers as they have engaged in these efforts.Entities:
Mesh:
Year: 2013 PMID: 23498296 PMCID: PMC3609413 DOI: 10.1016/j.amepre.2012.12.014
Source DB: PubMed Journal: Am J Prev Med ISSN: 0749-3797 Impact factor: 5.043